TRPV1 and neoplasm: Taking into account that patients with metastasis generally have a poor prognosis [83], on a selected group with similar tumor grade and stage without distant diagnosed metastasis (M0) and lymph node positivity (N0), we found that TRPV1 could differentiate survival successfully as a valuable and independent molecular marker (Table 1).